Search Results
122 items found for "Andrew Advani"
- Neurotransmitters: Potential Targets in Glioblastoma
Here, we provide an overview of the most novel advances concerning the role of neurotransmitters in the
- Structural view of G protein-coupled receptor signaling in the retinal rod outer segment
We summarize recent discoveries that have advanced our understanding of rod outer segment (ROS) morphology
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
understanding of one of the biggest classes of pharmaceutical targets by combining structural biology and advanced
- Emerging approaches for decoding neuropeptide transmission
Neuropeptides produce robust effects on behavior across species, and recent research has benefited from advances
- Single-molecule counting applied to the study of GPCR oligomerization
single-molecule localization microscopy-with a particular emphasis on the potential for these techniques to advance
- Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
pharmacokinetic results from the trial warrant further investigation, and the Company will actively pursue the advancement
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
These advances have paved the way for development of novel ligands for different therapeutic applications
- 📰 GPCR Weekly News, March 18 to 24, 2024
GPCR Research A multicolor suite for deciphering population coding of calcium and cAMP in vivo Cryo-EM advances Reviews, GPCRs, and more G protein-coupled receptor (GPCR) gene variants and human genetic disease Advances
- Targeting Intracellular Allosteric Sites in GPCRs
Recent advances in structural biology and pharmacology have revealed the existence of allosteric sites Recent advances in structural biology have allowed researchers to visualize the binding of allosteric Advances in understanding the structural and mechanistic aspects of biased GPCR signaling are crucial
- Community guidelines for GPCR ligand bias: IUPHAR review 32
consistency and clarity, as the basic receptor research and drug discovery communities continue to advance
- 📰 GPCR Weekly News, April 1 to 7, 2024
Samuel Hoare on Advanced data analysis for GPCR pharmacology, which will be held on Thursdays between Chemoattractant receptor signaling in humoral immunity Industry News Neurosterix launches with $63M to Advance
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
We also discuss how advancing technologies to discover nanobodies with tailored specificities may expand
- Allosteric modulation of GPCRs: From structural insights to in silico drug discovery
Recent advances in the structure determination of GPCRs bound to different types of allosteric modulators
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
Therefore, docking performance against GPCR targets can be estimated in advance based on docking target Receptor conformational sampling in advance of docking or receptor conformational adjustment after docking
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
Kenakin and Hoare on ' Applying Pharmacology to Drug Discovery ' and ' Advanced Data Analysis for GPCR us in the vibrant heart of Mexico City to connect with fellow scientists and delve into the latest advances
- G-protein-coupled receptors as therapeutic targets for glioblastoma
In this review, we focus on recent advances in G-protein-coupled receptor (GPCR) targets.
- Exploring the Breakthroughs in GPCR Research
Principles of Pharmacology in Drug Discovery II - Advanced Methods for the Optimization of Candidate October 3rd to 31st, 2024 Overview: Building on the basics covered in Course I, this course explores advanced
- 📰 GPCR Weekly News, October 16 to 22, 2023
localization of a light-activated neuronal GPCR shapes behavior Methods & Updates in GPCR Research Advancements Industry News The Leading GPCR Company in Immuno-Oncology, Domain Therapeutics, Presents Groundbreaking Advancements
- 📰 GPCR Weekly News, January 23 to 29, 2023
Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news Securities Global BioPharma Conference Orbit Discovery and Endevica Bio enter multi-target collaboration to advance
- Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric...
ligand selectivity and allosteric modulation in angiotensin receptors: IUPHAR Review 34 "Functional advances
- 📰 GPCR Weekly News, January 16 to 22, 2023
Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news of Directors GPCR Therapeutics launches multiple myeloma trial Salipro Biotech is attending the 3rd Advanced
- 📰 GPCR Weekly News - January 9 to 15, 2023
Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news Drugs, and more Modelling altered signalling of G-protein coupled receptors in inflamed environment to advance
- β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...
Furthermore, the utilisation of advanced NanoLuc/FlAsH-based biosensors reveals distinct conformational
- Prostaglandin signaling in ciliogenesis and development
This review outlines recent advances in understanding the functions and mechanisms of prostaglandin signaling
- Functional modulation of PTH1R activation and signaling by RAMP2
signaling of a GPCR that may provide a new venue for highly specific modulation of GPCR function and advanced
- Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of...
combination of the anti-PD-L1 antibody atezolizumab and nab-paclitaxel has shown clinical activity in advanced
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
This further underscores the need for advanced assay technologies and a deep understanding of cellular By understanding the intricacies of GPCR signaling and utilising advanced assay technologies, researchers
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
compound library for its industry-leading biology platform to identify potential GPCR targets and advance